Oculopharyngeal Muscular Dystrophy (OPMD)
Medical Management
Current treatment for OPMD focuses on managing symptoms, maintaining function, and preventing complications. Care is often provided by a team that may include a neurologist, speech-language pathologist, ophthalmologist, physical or occupational therapist, and other specialists as needed.
Dysphagia

Difficulty swallowing, or dysphagia, is common in OPMD. It can increase the risk of food or liquid entering the airway and may contribute to complications such as aspiration pneumonia, dehydration, or poor nutrition.
Swallowing difficulties may be managed with strategies such as changing the consistency of foods or liquids, adjusting eating and swallowing techniques, or using different head positions. A speech-language pathologist may be involved in evaluating swallowing and providing recommendations.
In some people with more advanced dysphagia, procedures such as cricopharyngeal dilation or cricopharyngeal myotomy may help improve swallowing. Feeding tubes may also be considered when swallowing becomes significantly impaired.
Limb weakness
Weakness in the muscles around the hips and shoulders can affect walking, balance, and everyday activities. Physical and occupational therapy may help people maintain mobility and independence.
Assistive devices, including canes, walkers, braces, and wheelchairs, may be used as muscle weakness progresses or when additional support with mobility is needed.
Ptosis
Drooping eyelids, or ptosis, can interfere with vision and, in some people, may lead to changes in head position to see more clearly.
A nonsurgical option to address ptosis is an eyelid crutch, an attachment placed on eyeglasses that helps support the eyelids and keep them open.
When ptosis significantly affects vision or daily activities, surgery may be considered. Surgical approaches can include a frontalis sling (frontal suspension), which uses the forehead muscle to help lift the eyelids.
Additional reading
- Trollet C, Boulinguiez A, Roth F, et al. Oculopharyngeal Muscular Dystrophy. 2001 Mar 8 [Updated 2020 Oct 22]. In: Adam MP, Bick S, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1126/
- Yu J, Deng J, Wang Z. Oculopharyngodistal myopathy. Curr Opin Neurol. 2022 Oct 1;35(5):637-644. doi: 10.1097/WCO.0000000000001089. Epub 2022 Aug 4. PMID: 35942670.
Last reviewed October 2026.


